Blancafort P - Search Results

1

[No authors listed] [No authors listed] PMID: 34465853

2

Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide.

Sorolla A, Ho D, Wang E, Evans CW, Ormonde CF, Rashwan R, Singh R, Iyer KS, Blancafort P. Sorolla A, et al. Among authors: blancafort p. Nanoscale. 2016 Apr 28;8(17):9343-53. doi: 10.1039/c5nr08331a. Nanoscale. 2016. PMID: 27089946

3

Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.

Garcia-Bloj B, Moses C, Sgro A, Plani-Lam J, Arooj M, Duffy C, Thiruvengadam S, Sorolla A, Rashwan R, Mancera RL, Leisewitz A, Swift-Scanlan T, Corvalan AH, Blancafort P. Garcia-Bloj B, et al. Among authors: blancafort p. Oncotarget. 2016 Sep 13;7(37):60535-60554. doi: 10.18632/oncotarget.11142. Oncotarget. 2016. PMID: 27528034 Free PMC article.

4

Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA.

Kretzmann JA, Ho D, Evans CW, Plani-Lam JHC, Garcia-Bloj B, Mohamed AE, O'Mara ML, Ford E, Tan DEK, Lister R, Blancafort P, Norret M, Iyer KS. Kretzmann JA, et al. Among authors: blancafort p. Chem Sci. 2017 Apr 1;8(4):2923-2930. doi: 10.1039/c7sc00097a. Epub 2017 Jan 27. Chem Sci. 2017. PMID: 28451358 Free PMC article.

5

Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells.

Shrestha S, Sorolla A, Fromont J, Blancafort P, Flematti GR. Shrestha S, et al. Among authors: blancafort p. Mar Drugs. 2018 Feb 8;16(2):53. doi: 10.3390/md16020053. Mar Drugs. 2018. PMID: 29419736 Free PMC article.

6

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers.

Wang E, Sorolla A, Cunningham PT, Bogdawa HM, Beck S, Golden E, Dewhurst RE, Florez L, Cruickshank MN, Hoffmann K, Hopkins RM, Kim J, Woo AJ, Watt PM, Blancafort P. Wang E, et al. Among authors: blancafort p. Oncogene. 2019 Jan;38(1):140-150. doi: 10.1038/s41388-018-0421-y. Epub 2018 Aug 3. Oncogene. 2019. PMID: 30076412 Free PMC article.

7

Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells.

Shrestha S, Sorolla A, Fromont J, Blancafort P, Flematti GR. Shrestha S, et al. Among authors: blancafort p. Mar Drugs. 2018 Oct 1;16(10):361. doi: 10.3390/md16100361. Mar Drugs. 2018. PMID: 30275391 Free PMC article.

8

Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides.

Sorolla A, Wang E, Clemons TD, Evans CW, Plani-Lam JH, Golden E, Dessauvagie B, Redfern AD, Swaminathan-Iyer K, Blancafort P. Sorolla A, et al. Among authors: blancafort p. Nanomedicine. 2019 Aug;20:102003. doi: 10.1016/j.nano.2019.04.006. Epub 2019 May 2. Nanomedicine. 2019. PMID: 31055077 Free article.

9

Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers.

Kretzmann JA, Evans CW, Moses C, Sorolla A, Kretzmann AL, Wang E, Ho D, Hackett MJ, Dessauvagie BF, Smith NM, Redfern AD, Waryah C, Norret M, Iyer KS, Blancafort P. Kretzmann JA, et al. Among authors: blancafort p. Chem Sci. 2019 Jun 27;10(33):7718-7727. doi: 10.1039/c9sc01432b. eCollection 2019 Sep 7. Chem Sci. 2019. PMID: 31588320 Free PMC article.

10

Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics.

Sorolla A, Wang E, Golden E, Duffy C, Henriques ST, Redfern AD, Blancafort P. Sorolla A, et al. Among authors: blancafort p. Oncogene. 2020 Feb;39(6):1167-1184. doi: 10.1038/s41388-019-1056-3. Epub 2019 Oct 21. Oncogene. 2020. PMID: 31636382 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page